25 XP   0   0   10

Gansu Longshenrongfa Pharmaceutical Industry Co Ltd
Buy, Hold or Sell?

Let's analyse Gansu Longshenrongfa Pharmaceutical Industry Co Ltd together

PenkeI guess you are interested in Gansu Longshenrongfa Pharmaceutical Industry Co Ltd. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Gansu Longshenrongfa Pharmaceutical Industry Co Ltd. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Gansu Longshenrongfa Pharmaceutical Industry Co Ltd

I send you an email if I find something interesting about Gansu Longshenrongfa Pharmaceutical Industry Co Ltd.

Quick analysis of Gansu Longshenrongfa Pharmaceutical Industry Co Ltd (30 sec.)










What can you expect buying and holding a share of Gansu Longshenrongfa Pharmaceutical Industry Co Ltd? (30 sec.)

How much money do you get?

How much money do you get?
¥0.00
When do you have the money?
1 year
How often do you get paid?
81.3%

What is your share worth?

Current worth
¥2.27
Expected worth in 1 year
¥2.09
How sure are you?
84.4%

+ What do you gain per year?

Total Gains per Share
¥-0.16
Return On Investment
-1.9%

For what price can you sell your share?

Current Price per Share
¥8.38
Expected price per share
¥6.3 - ¥9.5
How sure are you?
50%

1. Valuation of Gansu Longshenrongfa Pharmaceutical Industry Co Ltd (5 min.)




Live pricePrice per Share (EOD)

¥8.38

Intrinsic Value Per Share

¥-0.80 - ¥-0.99

Total Value Per Share

¥1.46 - ¥1.28

2. Growth of Gansu Longshenrongfa Pharmaceutical Industry Co Ltd (5 min.)




Is Gansu Longshenrongfa Pharmaceutical Industry Co Ltd growing?

Current yearPrevious yearGrowGrow %
How rich?$95.1m$101.9m-$5.9m-6.2%

How much money is Gansu Longshenrongfa Pharmaceutical Industry Co Ltd making?

Current yearPrevious yearGrowGrow %
Making money$2.3m$156.7k$2.1m93.3%
Net Profit Margin7.1%1.6%--

How much money comes from the company's main activities?

3. Financial Health of Gansu Longshenrongfa Pharmaceutical Industry Co Ltd (5 min.)




What can you expect buying and holding a share of Gansu Longshenrongfa Pharmaceutical Industry Co Ltd? (5 min.)

Welcome investor! Gansu Longshenrongfa Pharmaceutical Industry Co Ltd's management wants to use your money to grow the business. In return you get a share of Gansu Longshenrongfa Pharmaceutical Industry Co Ltd.

What can you expect buying and holding a share of Gansu Longshenrongfa Pharmaceutical Industry Co Ltd?

First you should know what it really means to hold a share of Gansu Longshenrongfa Pharmaceutical Industry Co Ltd. And how you can make/lose money.

Speculation

The Price per Share of Gansu Longshenrongfa Pharmaceutical Industry Co Ltd is ¥8.38. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Gansu Longshenrongfa Pharmaceutical Industry Co Ltd.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Gansu Longshenrongfa Pharmaceutical Industry Co Ltd, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is ¥2.27. Based on the TTM, the Book Value Change Per Share is ¥-0.04 per quarter. Based on the YOY, the Book Value Change Per Share is ¥0.01 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is ¥0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Gansu Longshenrongfa Pharmaceutical Industry Co Ltd.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 ¥% of Price per Share¥% of Price per Share¥% of Price per Share¥% of Price per Share¥% of Price per Share
Usd Eps0.010.1%0.010.1%0.000.0%0.000.0%0.000.0%
Usd Book Value Change Per Share0.010.1%-0.01-0.1%0.000.0%0.000.0%0.010.1%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share0.010.1%-0.01-0.1%0.000.0%0.000.1%0.010.1%
Usd Price Per Share1.38-1.33-1.63-1.10-1.85-
Price to Earnings Ratio51.82-57.09-304.76-550.27--167.37-
Price-to-Total Gains Ratio155.26-105.49-2,982.82-1,119.40-1,030.81-
Price to Book Ratio4.41-4.22-4.86-3.34-5.73-
Price-to-Total Gains Ratio155.26-105.49-2,982.82-1,119.40-1,030.81-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share1.159792
Number of shares862
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share-0.010.00
Usd Total Gains Per Share-0.010.00
Gains per Quarter (862 shares)-4.813.69
Gains per Year (862 shares)-19.2414.77
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
12-21-291135
24-42-4832720
36-64-6744035
48-85-8665350
510-106-10576765
612-127-12498080
714-148-143109395
816-169-16211107110
917-191-18113120125
1019-212-20014133140

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share4.00.00.0100.0%10.02.00.083.3%15.05.00.075.0%25.06.01.078.1%25.06.01.078.1%
Book Value Change Per Share3.01.00.075.0%10.02.00.083.3%15.05.00.075.0%23.08.01.071.9%23.08.01.071.9%
Dividend per Share4.00.00.0100.0%9.00.03.075.0%17.00.03.085.0%26.00.06.081.3%26.00.06.081.3%
Total Gains per Share3.01.00.075.0%10.02.00.083.3%16.04.00.080.0%27.05.00.084.4%27.05.00.084.4%

Fundamentals of Gansu Longshenrongfa Pharmaceutical Industry Co Ltd

About Gansu Longshenrongfa Pharmaceutical Industry Co Ltd

Gansu Longshenrongfa Pharmaceutical Industry CO.,LTD researches, develops, produces, and sells Chinese patent medicines, health food, and APIs in China and internationally. The company offers Xuanfei Zhicough mixture, Yuanhu Zhitong dropping pills, Qiwei Wenyang capsules, Maxing cough capsule, and Astragalus Angelica capsules. Gansu Longshenrongfa Pharmaceutical Industry CO.,LTD was founded in 2002 and is based in Lanzhou, China.

Fundamental data was last updated by Penke on 2024-03-26 01:40:04.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a profit.
Using its assets, the company is less efficient in making profit.
Using its investors money, the company is inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating less efficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is fair priced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Gansu Longshenrongfa Pharmaceutical Industry Co Ltd.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Gansu Longshenrongfa Pharmaceutical Industry Co Ltd earns for each ¥1 of revenue.

  • Above 10% is considered healthy but always compare Gansu Longshenrongfa Pharmaceutical Industry Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Net Profit Margin of 6.6% means that ¥0.07 for each ¥1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Gansu Longshenrongfa Pharmaceutical Industry Co Ltd:

  • The MRQ is 6.6%. The company is making a profit. +1
  • The TTM is 7.1%. The company is making a profit. +1
Trends
Current periodCompared to+/- 
MRQ6.6%TTM7.1%-0.4%
TTM7.1%YOY1.6%+5.4%
TTM7.1%5Y1.7%+5.3%
5Y1.7%10Y5.4%-3.7%
1.1.2. Return on Assets

Shows how efficient Gansu Longshenrongfa Pharmaceutical Industry Co Ltd is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Gansu Longshenrongfa Pharmaceutical Industry Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • 1.1% Return on Assets means that Gansu Longshenrongfa Pharmaceutical Industry Co Ltd generated ¥0.01 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Gansu Longshenrongfa Pharmaceutical Industry Co Ltd:

  • The MRQ is 1.1%. Using its assets, the company is less efficient in making profit.
  • The TTM is 1.5%. Using its assets, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ1.1%TTM1.5%-0.4%
TTM1.5%YOY0.1%+1.3%
TTM1.5%5Y0.4%+1.1%
5Y0.4%10Y0.6%-0.3%
1.1.3. Return on Equity

Shows how efficient Gansu Longshenrongfa Pharmaceutical Industry Co Ltd is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Gansu Longshenrongfa Pharmaceutical Industry Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • 2.4% Return on Equity means Gansu Longshenrongfa Pharmaceutical Industry Co Ltd generated ¥0.02 for each ¥1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Gansu Longshenrongfa Pharmaceutical Industry Co Ltd:

  • The MRQ is 2.4%. Using its investors money, the company is inefficient in making profit. -1
  • The TTM is 2.6%. Using its investors money, the company is inefficient in making profit. -1
Trends
Current periodCompared to+/- 
MRQ2.4%TTM2.6%-0.3%
TTM2.6%YOY0.2%+2.5%
TTM2.6%5Y0.6%+2.0%
5Y0.6%10Y0.9%-0.3%

1.2. Operating Efficiency of Gansu Longshenrongfa Pharmaceutical Industry Co Ltd.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Gansu Longshenrongfa Pharmaceutical Industry Co Ltd is operating .

  • Measures how much profit Gansu Longshenrongfa Pharmaceutical Industry Co Ltd makes for each ¥1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Gansu Longshenrongfa Pharmaceutical Industry Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • An Operating Margin of 8.3% means the company generated ¥0.08  for each ¥1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Gansu Longshenrongfa Pharmaceutical Industry Co Ltd:

  • The MRQ is 8.3%. The company is operating less efficient.
  • The TTM is 3.4%. The company is operating less efficient.
Trends
Current periodCompared to+/- 
MRQ8.3%TTM3.4%+4.9%
TTM3.4%YOY3.9%-0.5%
TTM3.4%5Y1.0%+2.4%
5Y1.0%10Y0.7%+0.4%
1.2.2. Operating Ratio

Measures how efficient Gansu Longshenrongfa Pharmaceutical Industry Co Ltd is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • An Operation Ratio of 1.24 means that the operating costs are ¥1.24 for each ¥1 in net sales.

Let's take a look of the Operating Ratio trends of Gansu Longshenrongfa Pharmaceutical Industry Co Ltd:

  • The MRQ is 1.243. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.297. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.243TTM1.297-0.054
TTM1.297YOY1.573-0.276
TTM1.2975Y1.563-0.266
5Y1.56310Y1.233+0.330

1.3. Liquidity of Gansu Longshenrongfa Pharmaceutical Industry Co Ltd.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Gansu Longshenrongfa Pharmaceutical Industry Co Ltd is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • A Current Ratio of 1.34 means the company has ¥1.34 in assets for each ¥1 in short-term debts.

Let's take a look of the Current Ratio trends of Gansu Longshenrongfa Pharmaceutical Industry Co Ltd:

  • The MRQ is 1.344. The company is just able to pay all its short-term debts.
  • The TTM is 1.821. The company is able to pay all its short-term debts. +1
Trends
Current periodCompared to+/- 
MRQ1.344TTM1.821-0.477
TTM1.821YOY4.568-2.747
TTM1.8215Y3.842-2.021
5Y3.84210Y2.596+1.246
1.3.2. Quick Ratio

Measures if Gansu Longshenrongfa Pharmaceutical Industry Co Ltd is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Gansu Longshenrongfa Pharmaceutical Industry Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Quick Ratio of 0.49 means the company can pay off ¥0.49 for each ¥1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Gansu Longshenrongfa Pharmaceutical Industry Co Ltd:

  • The MRQ is 0.488. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.781. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.488TTM0.781-0.294
TTM0.781YOY2.091-1.310
TTM0.7815Y2.090-1.309
5Y2.09010Y2.559-0.469

1.4. Solvency of Gansu Longshenrongfa Pharmaceutical Industry Co Ltd.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Gansu Longshenrongfa Pharmaceutical Industry Co Ltd assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Gansu Longshenrongfa Pharmaceutical Industry Co Ltd to Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Asset Ratio of 0.48 means that Gansu Longshenrongfa Pharmaceutical Industry Co Ltd assets are financed with 48.0% credit (debt) and the remaining percentage (100% - 48.0%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Gansu Longshenrongfa Pharmaceutical Industry Co Ltd:

  • The MRQ is 0.480. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.404. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.480TTM0.404+0.076
TTM0.404YOY0.113+0.292
TTM0.4045Y0.168+0.236
5Y0.16810Y0.166+0.002
1.4.2. Debt to Equity Ratio

Measures if Gansu Longshenrongfa Pharmaceutical Industry Co Ltd is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Gansu Longshenrongfa Pharmaceutical Industry Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Equity ratio of 103.1% means that company has ¥1.03 debt for each ¥1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Gansu Longshenrongfa Pharmaceutical Industry Co Ltd:

  • The MRQ is 1.031. The company is able to pay all its debts with equity. +1
  • The TTM is 0.834. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ1.031TTM0.834+0.197
TTM0.834YOY0.130+0.704
TTM0.8345Y0.267+0.567
5Y0.26710Y0.250+0.017

2. Market Valuation of Gansu Longshenrongfa Pharmaceutical Industry Co Ltd

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every ¥1 in earnings Gansu Longshenrongfa Pharmaceutical Industry Co Ltd generates.

  • Above 15 is considered overpriced but always compare Gansu Longshenrongfa Pharmaceutical Industry Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • A PE ratio of 51.82 means the investor is paying ¥51.82 for every ¥1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Gansu Longshenrongfa Pharmaceutical Industry Co Ltd:

  • The EOD is 43.426. Based on the earnings, the company is overpriced. -1
  • The MRQ is 51.821. Based on the earnings, the company is expensive. -2
  • The TTM is 57.086. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD43.426MRQ51.821-8.395
MRQ51.821TTM57.086-5.266
TTM57.086YOY304.759-247.673
TTM57.0865Y550.267-493.181
5Y550.26710Y-167.373+717.641
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Gansu Longshenrongfa Pharmaceutical Industry Co Ltd:

  • The EOD is 116.863. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is 139.455. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -236.898. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD116.863MRQ139.455-22.592
MRQ139.455TTM-236.898+376.353
TTM-236.898YOY141.542-378.440
TTM-236.8985Y-31.569-205.329
5Y-31.56910Y-19.177-12.392
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Gansu Longshenrongfa Pharmaceutical Industry Co Ltd is to cheap or to expensive compared to its book value.

Let's take a look of the Price to Book Ratio trends of Gansu Longshenrongfa Pharmaceutical Industry Co Ltd:

  • The EOD is 3.697. Based on the equity, the company is fair priced.
  • The MRQ is 4.412. Based on the equity, the company is fair priced.
  • The TTM is 4.221. Based on the equity, the company is fair priced.
Trends
Current periodCompared to+/- 
EOD3.697MRQ4.412-0.715
MRQ4.412TTM4.221+0.191
TTM4.221YOY4.856-0.635
TTM4.2215Y3.344+0.877
5Y3.34410Y5.727-2.382
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Gansu Longshenrongfa Pharmaceutical Industry Co Ltd compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.061-0.044+173%0.008+682%0.028+118%0.071-14%
Book Value Per Share--2.2672.285-1%2.427-7%2.391-5%2.260+0%
Current Ratio--1.3441.821-26%4.568-71%3.842-65%2.596-48%
Debt To Asset Ratio--0.4800.404+19%0.113+326%0.168+186%0.166+190%
Debt To Equity Ratio--1.0310.834+24%0.130+694%0.267+286%0.250+312%
Dividend Per Share--0.0040.004-12%0.000+9064%0.003+20%0.009-61%
Eps--0.0480.042+14%0.004+1192%0.011+359%0.016+198%
Free Cash Flow Per Share--0.018-0.048+370%0.021-16%0.007+157%-0.018+202%
Free Cash Flow To Equity Per Share--0.018-0.055+410%0.021-17%0.002+609%0.002+827%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%0.969+3%
Intrinsic Value_10Y_max---0.986--------
Intrinsic Value_10Y_min---0.803--------
Intrinsic Value_1Y_max--0.020--------
Intrinsic Value_1Y_min--0.020--------
Intrinsic Value_3Y_max---0.030--------
Intrinsic Value_3Y_min---0.027--------
Intrinsic Value_5Y_max---0.190--------
Intrinsic Value_5Y_min---0.169--------
Market Cap2542031032.960-19%3033450000.0002909836912.500+4%3571887375.000-15%2416228682.326+26%4076897000.304-26%
Net Profit Margin--0.0660.071-6%0.016+306%0.017+285%0.054+23%
Operating Margin--0.0830.034+143%0.039+114%0.010+696%0.007+1109%
Operating Ratio--1.2431.297-4%1.573-21%1.563-20%1.233+1%
Pb Ratio3.697-19%4.4124.221+5%4.856-9%3.344+32%5.727-23%
Pe Ratio43.426-19%51.82157.086-9%304.759-83%550.267-91%-167.373+423%
Price Per Share8.380-19%10.0009.593+4%11.775-15%7.965+26%13.349-25%
Price To Free Cash Flow Ratio116.863-19%139.455-236.898+270%141.542-1%-31.569+123%-19.177+114%
Price To Total Gains Ratio130.108-19%155.260105.492+47%2982.818-95%1119.396-86%1030.813-85%
Quick Ratio--0.4880.781-38%2.091-77%2.090-77%2.559-81%
Return On Assets--0.0110.015-24%0.001+725%0.004+201%0.006+74%
Return On Equity--0.0240.026-10%0.002+1419%0.006+289%0.009+156%
Total Gains Per Share--0.064-0.040+163%0.008+724%0.031+108%0.080-20%
Usd Book Value--95160388.67995937728.986-1%101911322.208-7%100408049.627-5%95773430.028-1%
Usd Book Value Change Per Share--0.008-0.006+173%0.001+682%0.004+118%0.010-14%
Usd Book Value Per Share--0.3140.316-1%0.336-7%0.331-5%0.313+0%
Usd Dividend Per Share--0.0000.001-12%0.000+9064%0.000+20%0.001-61%
Usd Eps--0.0070.006+14%0.001+1192%0.001+359%0.002+198%
Usd Free Cash Flow--752625.324-2029926.789+370%892234.089-16%292427.992+157%-545127.730+172%
Usd Free Cash Flow Per Share--0.002-0.007+370%0.003-16%0.001+157%-0.003+202%
Usd Free Cash Flow To Equity Per Share--0.002-0.008+410%0.003-17%0.000+609%0.000+827%
Usd Market Cap351817094.962-19%419829480.000402721428.690+4%494349212.700-15%334406049.634+26%564242544.842-26%
Usd Price Per Share1.160-19%1.3841.328+4%1.630-15%1.102+26%1.847-25%
Usd Profit--2025399.3372325306.132-13%156716.129+1192%552189.470+267%748480.375+171%
Usd Revenue--30563428.27334671190.558-12%11923908.221+156%14235010.922+115%12286163.942+149%
Usd Total Gains Per Share--0.009-0.006+163%0.001+724%0.004+108%0.011-20%
 EOD+4 -4MRQTTM+18 -17YOY+19 -165Y+24 -1110Y+18 -18

3.2. Fundamental Score

Let's check the fundamental score of Gansu Longshenrongfa Pharmaceutical Industry Co Ltd based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1543.426
Price to Book Ratio (EOD)Between0-13.697
Net Profit Margin (MRQ)Greater than00.066
Operating Margin (MRQ)Greater than00.083
Quick Ratio (MRQ)Greater than10.488
Current Ratio (MRQ)Greater than11.344
Debt to Asset Ratio (MRQ)Less than10.480
Debt to Equity Ratio (MRQ)Less than11.031
Return on Equity (MRQ)Greater than0.150.024
Return on Assets (MRQ)Greater than0.050.011
Total4/10 (40.0%)

3.3. Technical Score

Let's check the technical score of Gansu Longshenrongfa Pharmaceutical Industry Co Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5047.911
Ma 20Greater thanMa 508.493
Ma 50Greater thanMa 1008.413
Ma 100Greater thanMa 2009.352
OpenGreater thanClose8.200
Total1/5 (20.0%)



Latest Balance Sheet

Balance Sheet of 2023-09-30. Currency in CNY. All numbers in thousands.

Summary
Total Assets1,323,425
Total Liabilities635,850
Total Stockholder Equity616,774
 As reported
Total Liabilities 635,850
Total Stockholder Equity+ 616,774
Total Assets = 1,323,425

Assets

Total Assets1,323,425
Total Current Assets670,030
Long-term Assets653,395
Total Current Assets
Cash And Cash Equivalents 263,444
Net Receivables 243,057
Inventory 126,866
Other Current Assets 36,664
Total Current Assets  (as reported)670,030
Total Current Assets  (calculated)670,030
+/- 0
Long-term Assets
Property Plant Equipment 402,173
Goodwill 13,724
Intangible Assets 61,265
Other Assets 122,033
Long-term Assets  (as reported)653,395
Long-term Assets  (calculated)599,195
+/- 54,200

Liabilities & Shareholders' Equity

Total Current Liabilities498,525
Long-term Liabilities137,326
Total Stockholder Equity616,774
Total Current Liabilities
Short Long Term Debt 30,030
Accounts payable 329,026
Other Current Liabilities 138,461
Total Current Liabilities  (as reported)498,525
Total Current Liabilities  (calculated)497,517
+/- 1,007
Long-term Liabilities
Long term Debt 110,838
Other Liabilities 26,488
Deferred Long Term Liability 99
Long-term Liabilities  (as reported)137,326
Long-term Liabilities  (calculated)137,425
+/- 99
Total Stockholder Equity
Common Stock303,345
Retained Earnings 257,673
Total Stockholder Equity (as reported)616,774
Total Stockholder Equity (calculated)561,018
+/- 55,756
Other
Capital Stock303,345
Common Stock Shares Outstanding 303,345
Net Invested Capital 757,642
Net Tangible Assets 541,785
Net Working Capital 171,506
Property Plant and Equipment Gross 402,173



Balance Sheet

Currency in CNY. All numbers in thousands.

 Trend2023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312014-12-312013-12-312012-12-31
> Total Assets 
294,527
453,233
476,858
646,742
0
635,569
896,549
763,476
773,260
766,070
780,589
782,230
787,532
771,029
778,571
778,514
794,033
790,801
807,896
810,146
866,172
848,682
868,174
866,661
820,051
815,325
798,780
824,073
807,500
841,355
847,840
912,793
1,272,481
1,303,128
1,323,425
1,323,4251,303,1281,272,481912,793847,840841,355807,500824,073798,780815,325820,051866,661868,174848,682866,172810,146807,896790,801794,033778,514778,571771,029787,532782,230780,589766,070773,260763,476896,549635,5690646,742476,858453,233294,527
   > Total Current Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
269,327
273,656
293,732
276,304
288,824
279,261
341,337
325,081
346,294
333,101
291,253
294,085
274,122
308,700
291,386
328,568
336,855
402,587
673,721
683,206
670,030
670,030683,206673,721402,587336,855328,568291,386308,700274,122294,085291,253333,101346,294325,081341,337279,261288,824276,304293,732273,656269,32700000000000000
       Cash And Cash Equivalents 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
19,941
63,029
38,147
27,153
35,685
51,634
65,608
70,510
99,204
118,189
70,759
49,860
61,708
99,121
86,128
113,506
98,490
97,834
276,918
258,093
263,444
263,444258,093276,91897,83498,490113,50686,12899,12161,70849,86070,759118,18999,20470,51065,60851,63435,68527,15338,14763,02919,94100000000000000
       Short-term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
20,000
0
0
0
0
0
0
0
0
10,000
10,000
0
15,000
0
0
0
0
0
0
00000015,000010,00010,0000000000020,0000000000000000000
       Net Receivables 
45,913
51,379
46,501
94,277
0
115,830
118,906
136,999
155,171
160,568
176,717
170,207
193,746
203,867
199,456
175,195
185,874
199,699
191,751
183,158
181,631
157,210
148,540
169,734
165,129
146,080
132,726
145,976
131,078
136,032
142,415
203,584
241,971
265,631
243,057
243,057265,631241,971203,584142,415136,032131,078145,976132,726146,080165,129169,734148,540157,210181,631183,158191,751199,699185,874175,195199,456203,867193,746170,207176,717160,568155,171136,999118,906115,830094,27746,50151,37945,913
       Other Current Assets 
25,921
25,430
40,080
8,357
0
14,872
45,165
4,551
5,494
7,785
28,642
8,678
25,218
2,586
27,075
2,997
32
134
68
4,744
26,623
15,613
18,938
2,586
13,425
25,667
8,835
7,638
12,740
12,560
12,141
37,236
421
31,545
36,664
36,66431,54542137,23612,14112,56012,7407,6388,83525,66713,4252,58618,93815,61326,6234,74468134322,99727,0752,58625,2188,67828,6427,7855,4944,55145,16514,87208,35740,08025,43025,921
   > Long-term Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
500,301
514,497
519,072
530,886
524,835
523,602
521,879
533,560
528,798
521,240
524,658
515,373
516,114
512,787
510,985
510,206
598,760
619,921
653,395
653,395619,921598,760510,206510,985512,787516,114515,373524,658521,240528,798533,560521,879523,602524,835530,886519,072514,497500,3010000000000000000
       Property Plant Equipment 
30,078
86,096
150,250
355,211
0
345,839
318,960
349,671
347,033
356,868
347,226
382,699
378,968
375,108
314,607
310,381
306,642
302,897
308,719
312,984
318,263
318,536
314,563
326,763
322,805
302,905
301,536
305,205
302,566
299,187
298,402
267,907
334,931
361,999
402,173
402,173361,999334,931267,907298,402299,187302,566305,205301,536302,905322,805326,763314,563318,536318,263312,984308,719302,897306,642310,381314,607375,108378,968382,699347,226356,868347,033349,671318,960345,8390355,211150,25086,09630,078
       Goodwill 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
18,782
18,782
18,507
18,507
18,507
18,507
18,507
18,507
18,507
18,507
13,724
13,724
13,724
13,724
13,724
13,724
13,724
13,724
13,72413,72413,72413,72413,72413,72413,72413,72418,50718,50718,50718,50718,50718,50718,50718,50718,78218,78200000000000000000
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
54,200
54,200
54,200
54,200
54,200
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000054,20054,20054,20054,20054,20000000000000000
       Intangible Assets 
1,789
1,708
1,642
1,615
0
47,872
47,620
51,773
51,504
52,621
50,856
46,804
46,540
46,277
53,627
53,336
53,009
47
52,354
52,154
51,825
51,590
52,333
52,007
51,694
51,382
51,069
50,744
50,433
55,413
55,075
54,737
61,775
61,634
61,265
61,26561,63461,77554,73755,07555,41350,43350,74451,06951,38251,69452,00752,33351,59051,82552,15452,3544753,00953,33653,62746,27746,54046,80450,85652,62151,50451,77347,62047,87201,6151,6421,7081,789
       Long-term Assets Other 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
15,448
15,467
15,040
23,724
13,216
11,055
327,619
11,575
11,575
7,343
13,056
6,075
6,075
6,142
6,075
182
14,048
8,110
2,622
2,6228,11014,0481826,0756,1426,0756,07513,0567,34311,57511,575327,61911,05513,21623,72415,04015,46715,4480000000000000000
> Total Liabilities 
123,068
134,893
115,073
241,169
0
205,367
204,921
59,740
61,860
57,072
72,615
70,037
68,920
51,796
59,380
57,684
66,519
59,083
77,950
71,262
126,304
122,503
142,085
127,528
80,678
75,217
66,769
91,237
73,921
103,803
106,393
149,661
619,544
634,004
635,850
635,850634,004619,544149,661106,393103,80373,92191,23766,76975,21780,678127,528142,085122,503126,30471,26277,95059,08366,51957,68459,38051,79668,92070,03772,61557,07261,86059,740204,921205,3670241,169115,073134,893123,068
   > Total Current Liabilities 
95,941
76,850
42,977
67,318
0
32,112
31,964
40,081
44,874
40,458
56,375
52,678
51,934
35,183
43,140
51,817
61,025
53,962
73,202
66,880
122,295
118,867
138,734
103,481
57,458
52,823
45,189
68,316
51,162
81,208
83,961
127,393
480,266
496,426
498,525
498,525496,426480,266127,39383,96181,20851,16268,31645,18952,82357,458103,481138,734118,867122,29566,88073,20253,96261,02551,81743,14035,18351,93452,67856,37540,45844,87440,08131,96432,112067,31842,97776,85095,941
       Short-term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
10,000
10,000
10,000
20,000
24,034
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000024,03420,00010,00010,00010,000000000000000000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
10,000
10,000
10,000
20,000
24,034
44,046
24,043
20,018
70,066
20,018
0
0
0
0
0
0
0
30,033
30,030
30,030
30,03030,03030,033000000020,01870,06620,01824,04344,04624,03420,00010,00010,00010,000000000000000000
       Accounts payable 
76,303
64,395
27,198
31,960
0
16,403
17,939
25,528
28,193
27,736
39,185
30,683
29,238
23,702
20,877
19,774
30,154
17,359
19,679
20,275
33,778
21,759
19,971
6,528
14,821
23,723
24,478
32,633
22,282
52,932
60,023
69,887
282,859
331,660
329,026
329,026331,660282,85969,88760,02352,93222,28232,63324,47823,72314,8216,52819,97121,75933,77820,27519,67917,35930,15419,77420,87723,70229,23830,68339,18527,73628,19325,52817,93916,403031,96027,19864,39576,303
       Other Current Liabilities 
19,637
12,454
15,779
15,358
0
15,708
14,025
14,553
16,681
12,723
17,190
21,995
22,697
11,480
21,660
14,312
10,000
10,000
10,000
16,312
43,670
14,650
14,237
21,268
21,969
28,600
19,616
29,439
28,594
20,822
23,050
1,646
4,268
120,820
138,461
138,461120,8204,2681,64623,05020,82228,59429,43919,61628,60021,96921,26814,23714,65043,67016,31210,00010,00010,00014,31221,66011,48022,69721,99517,19012,72316,68114,55314,02515,708015,35815,77912,45419,637
   > Long-term Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
5,494
5,121
4,748
4,382
4,009
3,636
3,351
24,047
23,220
22,394
21,580
22,922
22,758
22,595
22,432
22,268
139,279
137,578
137,326
137,326137,578139,27922,26822,43222,59522,75822,92221,58022,39423,22024,0473,3513,6364,0094,3824,7485,1215,4940000000000000000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
142
0
0
0
0
0
0
0
0
0
0
0
0
0
4,317
0
0
0
0
111
99
9911100004,317000000000000014200000000000000
> Total Stockholder Equity
171,460
318,340
361,785
405,573
405,573
430,202
691,628
703,736
711,400
708,998
707,974
712,193
718,611
719,233
719,191
720,831
727,514
725,840
723,241
730,559
730,768
716,984
714,765
729,356
729,548
729,650
721,169
720,250
720,861
722,211
725,699
746,077
589,952
602,140
616,774
616,774602,140589,952746,077725,699722,211720,861720,250721,169729,650729,548729,356714,765716,984730,768730,559723,241725,840727,514720,831719,191719,233718,611712,193707,974708,998711,400703,736691,628430,202405,573405,573361,785318,340171,460
   Common Stock
45,000
65,000
65,000
65,000
0
65,000
86,670
86,670
86,670
303,345
303,345
303,345
303,345
303,345
303,345
303,345
303,345
303,345
303,345
303,345
303,345
303,345
303,345
303,345
303,345
303,345
303,345
303,345
303,345
303,345
303,345
303,345
0
303,345
303,345
303,345303,3450303,345303,345303,345303,345303,345303,345303,345303,345303,345303,345303,345303,345303,345303,345303,345303,345303,345303,345303,345303,345303,345303,345303,34586,67086,67086,67065,000065,00065,00065,00045,000
   Retained Earnings 
31,350
60,430
103,875
147,663
0
172,292
185,229
194,916
202,567
174,165
173,141
177,360
183,778
184,400
184,358
185,997
164,792
163,118
160,519
195,725
195,934
182,151
179,932
194,523
194,714
194,817
186,336
185,417
186,027
187,378
190,866
211,243
201,354
243,039
257,673
257,673243,039201,354211,243190,866187,378186,027185,417186,336194,817194,714194,523179,932182,151195,934195,725160,519163,118164,792185,997184,358184,400183,778177,360173,141174,165202,567194,916185,229172,2920147,663103,87560,43031,350
   Capital Surplus 00000000000000000000000000000000000
   Treasury Stock00000000000000000000000000000000000
   Other Stockholders Equity 00000000000000000000000000000000000



Balance Sheet

Currency in CNY. All numbers in thousands.




Cash Flow

Currency in CNY. All numbers in thousands.




Income Statement

Currency in CNY. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue824,449
Cost of Revenue-335,251
Gross Profit489,198489,198
 
Operating Income (+$)
Gross Profit489,198
Operating Expense-734,135
Operating Income90,314-244,937
 
Operating Expense (+$)
Research Development13,769
Selling General Administrative357,877
Selling And Marketing Expenses-
Operating Expense734,135371,646
 
Net Interest Income (+$)
Interest Income750
Interest Expense-2,366
Other Finance Cost-4,506
Net Interest Income2,891
 
Pretax Income (+$)
Operating Income90,314
Net Interest Income2,891
Other Non-Operating Income Expenses-
Income Before Tax (EBT)82,63790,314
EBIT - interestExpense = -2,366
56,632
58,998
Interest Expense2,366
Earnings Before Interest and Taxes (EBIT)-85,002
Earnings Before Interest and Taxes (EBITDA)-
 
After tax Income (+$)
Income Before Tax82,637
Tax Provision-8,464
Net Income From Continuing Ops74,17274,172
Net Income56,632
Net Income Applicable To Common Shares-
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses-
Total Other Income/Expenses Net--2,891
 

Technical Analysis of Gansu Longshenrongfa Pharmaceutical Industry Co Ltd
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Gansu Longshenrongfa Pharmaceutical Industry Co Ltd. The general trend of Gansu Longshenrongfa Pharmaceutical Industry Co Ltd is BEARISH with 71.4% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Gansu Longshenrongfa Pharmaceutical Industry Co Ltd's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-71.4%) Bearish trend (71.4%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Gansu Longshenrongfa Pharmaceutical Industry Co Ltd.

The long score for the Support & Resistance is 1/1.
The longshort score for the Support & Resistance is 1/(-1 +1).

  • Around support: The price is currently trading around a support level. This can be considered as a potential entry level. +1

The bullish price targets are: 9.11 < 9.12 < 9.5.

The bearish price targets are: 8.05 > 6.3.

Tweet this
Gansu Longshenrongfa Pharmaceutical Industry Co Ltd Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Gansu Longshenrongfa Pharmaceutical Industry Co Ltd. The current mas is .

The long score for the Moving Averages is 2/14.
The longshort score for the Moving Averages is -10/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Gansu Longshenrongfa Pharmaceutical Industry Co Ltd Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Gansu Longshenrongfa Pharmaceutical Industry Co Ltd. The current macd is 0.01101161.

The long score for the Moving Average Convergence/Divergence (MACD) is 1/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -2/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Gansu Longshenrongfa Pharmaceutical Industry Co Ltd price going down in the near term. -2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for Gansu Longshenrongfa Pharmaceutical Industry Co Ltd. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the Gansu Longshenrongfa Pharmaceutical Industry Co Ltd price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
Gansu Longshenrongfa Pharmaceutical Industry Co Ltd Daily Moving Average Convergence/Divergence (MACD) ChartGansu Longshenrongfa Pharmaceutical Industry Co Ltd Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Gansu Longshenrongfa Pharmaceutical Industry Co Ltd. The current adx is 14.96.

The long score for the Directional Movement Index (DMI) is 1/7.
The longshort score for the Directional Movement Index (DMI) is 1/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Gansu Longshenrongfa Pharmaceutical Industry Co Ltd shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX < 25 && ADX trending down: The ADX is below 25 and indicates a weak or no trend. Also, the ADX is declining so there is no trend indication.
Gansu Longshenrongfa Pharmaceutical Industry Co Ltd Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Gansu Longshenrongfa Pharmaceutical Industry Co Ltd. The current sar is 8.96263394.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Gansu Longshenrongfa Pharmaceutical Industry Co Ltd Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Gansu Longshenrongfa Pharmaceutical Industry Co Ltd. The current rsi is 47.91. The current phase is Continuation in bear market.

The long score for the Relative Strength Index (RSI) is 1/13.
The longshort score for the Relative Strength Index (RSI) is -2/(-13 +13).

  • Continuation in bear market: Downtrend continues after a consolidation or pullback. Hold or add to short positions.
  • Trending up: The RSI is trending up. +1
Gansu Longshenrongfa Pharmaceutical Industry Co Ltd Daily Relative Strength Index (RSI) ChartGansu Longshenrongfa Pharmaceutical Industry Co Ltd Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Gansu Longshenrongfa Pharmaceutical Industry Co Ltd. The current phase is Continuation in bear market.

The long score for the Stochastic Oscillator is 3/6.
The longshort score for the Stochastic Oscillator is 2/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Gansu Longshenrongfa Pharmaceutical Industry Co Ltd price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
Gansu Longshenrongfa Pharmaceutical Industry Co Ltd Daily Stochastic Oscillator ChartGansu Longshenrongfa Pharmaceutical Industry Co Ltd Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Gansu Longshenrongfa Pharmaceutical Industry Co Ltd. The current cci is -57.37018425.

Gansu Longshenrongfa Pharmaceutical Industry Co Ltd Daily Commodity Channel Index (CCI) ChartGansu Longshenrongfa Pharmaceutical Industry Co Ltd Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Gansu Longshenrongfa Pharmaceutical Industry Co Ltd. The current cmo is -7.80281385.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Gansu Longshenrongfa Pharmaceutical Industry Co Ltd Daily Chande Momentum Oscillator (CMO) ChartGansu Longshenrongfa Pharmaceutical Industry Co Ltd Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Gansu Longshenrongfa Pharmaceutical Industry Co Ltd. The current willr is -69.1588785.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Gansu Longshenrongfa Pharmaceutical Industry Co Ltd is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Gansu Longshenrongfa Pharmaceutical Industry Co Ltd Daily Williams %R ChartGansu Longshenrongfa Pharmaceutical Industry Co Ltd Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Gansu Longshenrongfa Pharmaceutical Industry Co Ltd.

Gansu Longshenrongfa Pharmaceutical Industry Co Ltd Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Gansu Longshenrongfa Pharmaceutical Industry Co Ltd. The current atr is 0.38291091.

Gansu Longshenrongfa Pharmaceutical Industry Co Ltd Daily Average True Range (ATR) ChartGansu Longshenrongfa Pharmaceutical Industry Co Ltd Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Gansu Longshenrongfa Pharmaceutical Industry Co Ltd. The current obv is 659,549,823.

Gansu Longshenrongfa Pharmaceutical Industry Co Ltd Daily On-Balance Volume (OBV) ChartGansu Longshenrongfa Pharmaceutical Industry Co Ltd Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Gansu Longshenrongfa Pharmaceutical Industry Co Ltd. The current mfi is 60.10.

The long score for the Money Flow Index (MFI) is 1/2.
The longshort score for the Money Flow Index (MFI) is 1/(-2 +2).

  • MFI > 50: +1
Gansu Longshenrongfa Pharmaceutical Industry Co Ltd Daily Money Flow Index (MFI) ChartGansu Longshenrongfa Pharmaceutical Industry Co Ltd Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Gansu Longshenrongfa Pharmaceutical Industry Co Ltd.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-06STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-11-07STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-08STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-11-09STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-15STOCH SHORT EXITThe %K line crosses above the %D line.
2023-11-16STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-17STOCH SHORT EXITThe %K line crosses above the %D line.
2023-11-20WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-11-21STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-23CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-11-24STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-11-27RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-11-28SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2023-12-04STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-05MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2023-12-06STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-07WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-11STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-14STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-19STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2023-12-21DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2023-12-22STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-25STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-26STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-27STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-02DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-01-03MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-04STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-05CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-08SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-09MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-01-10CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-01-11STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-15STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-16CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-01-18DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-19STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-22BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-23STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-01-24RSI LONG ENTRY SHORT CLOSE30 crossover to upside
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-01-29STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-30CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-31ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-02STOCH SHORT EXITThe %K line crosses above the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-02-05STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-06STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-07WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-08SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
RSI LONG ENTRY SHORT CLOSE30 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-20MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-02-22DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-26WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-28STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-29DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-01STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-04DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-05STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-07CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-08DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-03-11DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-12CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-03-13STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-15STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-18CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-03-19WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-03-21STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-22SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-03-25CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-26MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-03-27WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-28STOCH SHORT EXITThe %K line crosses above the %D line.

6.3. Candlestick Patterns

Gansu Longshenrongfa Pharmaceutical Industry Co Ltd Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Gansu Longshenrongfa Pharmaceutical Industry Co Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5047.911
Ma 20Greater thanMa 508.493
Ma 50Greater thanMa 1008.413
Ma 100Greater thanMa 2009.352
OpenGreater thanClose8.200
Total1/5 (20.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Gansu Longshenrongfa Pharmaceutical Industry Co Ltd with someone you think should read this too:
  • Are you bullish or bearish on Gansu Longshenrongfa Pharmaceutical Industry Co Ltd? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Gansu Longshenrongfa Pharmaceutical Industry Co Ltd? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Gansu Longshenrongfa Pharmaceutical Industry Co Ltd

I send you an email if I find something interesting about Gansu Longshenrongfa Pharmaceutical Industry Co Ltd.


Comments

How you think about this?

Leave a comment

Stay informed about Gansu Longshenrongfa Pharmaceutical Industry Co Ltd.

Receive notifications about Gansu Longshenrongfa Pharmaceutical Industry Co Ltd in your mailbox!